back to company universe
Healthcare

Embleema

We accelerate new drug releases to patients by providing faster, regulatory-grade real-world data to life sciences and regulators.

sources
1
Evidence entries preserved.
affiliations
1
Techstars
competitors
6
Mapped from High Signal graph features.
status
generated
D1 lookup
last updated
2026-07-15
16:41 UTC
source evidence
Why this company exists here

Techstars

techstars-portfolio #2031

We accelerate new drug releases to patients by providing faster, regulatory-grade real-world data to life sciences and regulators.

source
generated read
High Signal interpretation

Embleema is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction
Product facets
life sciencespatientsregulatorsnew drug releases
mapping method
Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

Companies similar to Embleema

Healthcare · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

Ritivel

match 85

Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster. Every month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and more importantly, delays treatment for thousands of patients who need it. Yet regulatory teams are stuck in a painful, months-long process: synthesizing thousands of pages of clini

shared extracted concepts: patients; shared product terms: drug, patient, faster, regulatory; shared product theme: health and clinical care

Frekil

match 73

Today, it takes months to understand how drugs perform in the real world, delaying safety insights and leaving patients exposed to unknown risks and benefits for far too long. Frekil turns that months-long process into minutes, with full auditability and scientific rigor. Frekil accelerates real world evidence (RWE) generation for life sciences companies on their own clinical data from months to minutes. It connects to fragmented clinical data (EHR, Claims, etc.) and lets teams run end-to-end st

shared extracted concept terms: life, science; shared product terms: accelerate, drug, patient, real; shared product theme: health and clinical care

KemNet

match 54

KemNet supplies pharmacies with premium reformulations of popular drugs that are more useful for specific groups of patients. For example, more than 30 pharmacies rely on KemNet to supply reformulated products for erectile dysfunction that work up to 8 times faster than alternatives. In addition to sexual function, products reformulated for novel drug delivery and supplied on KemNet include medications for hair growth, pain, weight loss and women's health.

shared extracted concepts: patients; shared product terms: drug, patient, faster; shared product theme: health and clinical care; same category: Healthcare

PostEra

match 49

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discov

shared extracted concepts: patients; shared product terms: accelerate, drug, patient, science; shared product theme: health and clinical care

Quinn

match 46

Quinn makes the highest-stakes scientific decisions in drug development. Which drugs to bet on, what to develop next, how to get them to patients. In days instead of months.

shared extracted concepts: patients; shared product terms: drug, patient; shared product theme: health and clinical care; same category: Healthcare

Synthio Labs

match 44

The intelligence layer behind modern life sciences engagement, enabling compliant, continuous conversations across HCPs, patients, and field teams

shared extracted concepts: patients; shared product terms: patient, life, science; shared product theme: health and clinical care; same category: Healthcare